MINERALYS THERAPEUTICS's chart data is dated 2026-10-07. There is no active technical signal. There are 0 published signal records.
MINERALYS THERAPEUTICS last closed at $22.09 (+0.64%) on 2026-10-07. Listed on Nasdaq. Trailing 12 months PER is -5.4×. Its overall grade ranks 580 of 737 stocks in Healthcare.
About this company
MINERALYS THERAPEUTICS last closed at $22.09 (+0.64%) on 2026-10-07. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 580/737
Valuation grade A-
Related stocks
- AbbVieCompetitor
원발성 알도스테론증·고혈압 등 대사/심혈관 영역에서 치료제 경쟁 가능성이 큼
- AstraZenecaCompetitor
고혈압·심혈관 질환 관련 신약 개발 경쟁사로 비교됨
- BayerCompetitor
심혈관·신장 질환 치료제 포트폴리오와 경쟁 관계
About MINERALYS THERAPEUTICS
- What technical signals does MINERALYS THERAPEUTICS (MLYS) have?
- MINERALYS THERAPEUTICS current technical signals: no active technical signal.
- Is MINERALYS THERAPEUTICS a cup-and-handle pattern?
- No. MINERALYS THERAPEUTICS has no valid Cup signal right now.
- What published figures are available for MINERALYS THERAPEUTICS?
- Market cap: $1.75B. Trailing 12 months PER: -5.4×. Latest quarter PBR: 3.40×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about MINERALYS THERAPEUTICS, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.